Home » RegeneRx Awarded $3 Million Grant From NIH
RegeneRx Awarded $3 Million Grant From NIH
RegeneRx Biopharmaceuticals announced Thursday that it has been awarded a $3 million grant from the NIH’s National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352 … for patients who have suffered an acute myocardial infarction.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May